ISSN: 2577-4328
Authors: Bind V and Kumar A*
The orphan drugs or products were not very economically beneficial for pharmaceutical industry due to less number of patients. However, these rare diseases have no any satisfactory treatment in the markets. Currently after so much development many patients are suffering. The government of various countries aware more nowadays, taking more steps against such cases and also taking attention for the development of such products for human welfare. According to UNICEF (US) the number of Orphans children’s in countries around the world about 2.7 million. The Eastern Europe is placed at the highest rate in the world for drops. In Asia, China on top but when we saw in INDIA, the government reported approximately there are 20 million orphans and abandoned children. In conclusion, there is more attention needs for such rare cases.
Keywords: Rare Disease; Orphan Drugs; Patients; Disable; Suffering
